货号: CL-0041
Price: ¥1400 ¥1400
生长培养基: RPMI-1640[PM150110]+10% FBS[164210]+10 μg/mL Insulin[PB180432]+1% P/S[PB180120]
产品信息
产品名称 | BT-549(人乳腺管癌细胞) |
别称 | BT 549; BT.549; BT549 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 |
冻存液:55% 基础培养基+40% FBS+5% DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:RPMI-1640[PM150110]+10% FBS[164210]+10 μg/mL Insulin[PB180432]+1% P/S[PB180120] 培养条件: 气相:空气,95%;CO₂,5%, 温度:37℃ |
培养方案B(可选) |
生长培养基: 培养条件: 气相:, 温度:37℃ |
推荐传代比例 | 1:2-1:4 |
推荐换液频率 | 2-3次/周 |
参考资料(来源文献)
背景描述 | BT-549细胞的来源组织是一个乳头状侵入性导管瘤,7个局部淋巴结中3个已有转移。由此组织建立的BT-549细胞是多态性的,包括上皮细胞样组分和多核巨细胞。 |
年龄(性别) | 72Y Female |
组织来源 | 乳腺 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 乳腺癌细胞 |
生物安全等级 | BSL-1 |
STR位点信息
STR鉴定图
-
Upregulation of the ferroptosis-related STEAP3 gene is a specific predictor of poor triple-negative breast cancer patient outcomes(2023)
作者:Yuan Lifang, Liu Jiannan, Bao Lei, Qu Huajun, Xiang Jinyu, Sun Ping
期刊:Frontiers in Oncology
影响因子:4.7
引用产品: MCF 10A 细胞, MDA-MB-231 细胞, BT-549 细胞, MDA-MB-468 细胞, MCF7 [MCF-7] 细胞, T-47D 细胞, BT-474 [BT474] 细胞
-
Potentiated effects of lactate receptor GPR81 on immune microenvironment in breast cancer(2023)
作者:Shenchao Guo, Jianliang Zhou, Pengrong Lou, Lijuan Weng, Xiaoxian Ye, Jianxin Guo, Huan Liu, Ruishuang Ma
期刊:MOLECULAR CARCINOGENESIS
DOI:10.1002/mc.23582
影响因子:4.6
-
Low-dose aspirin can inhibit exosomal release induced by radiotherapy in breast cancer and attenuate its inhibitory effect on NK cell proliferation(2023)
作者:Li Wang, Zaoxiu Hu, Ceshi Chen, Ting Chen, Zhihong Yao, Wenhui Li, Zuozhang Yang
期刊:Cancer Medicine
影响因子:4.0
-
The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer(2023)
作者:Jing Li, Dianbao Zhang, Zhiwei Liu, Yukun Wang, Xinyang Li, Ziming Wang, Gaofeng Liang, Xiang Yuan, Yuanpei Li, Andrzej L. Komorowski, Warren Matthew Rozen, Armando Orlandi, Kazuaki Takabe, Gianluca Franceschini, Guy Jerusalem, Xinshuai Wang
期刊:Annals of Translational Medicine
影响因子:3.6
引用产品: MDA-MB-468 细胞, BT-549 细胞
-
TTK inhibition activates STING signal and promotes anti-PD1 immunotherapy in breast cancer(2023)
作者:Xiang Hu, Guangmei Li, Sisi Li, Qiwei Wang, Yuerong Wang, Peidong Zhang, Tianqiong Yang, Bo Yang, Luoting Yu, Zhihao Liu
期刊:BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
DOI:10.1016/j.bbrc.2023.149388
影响因子:3.1
引用产品: 4T1 细胞, 293T [HEK-293T] 细胞, MDA-MB-231 细胞, MDA-MB-468 细胞, BT-549 细胞, BT-474 [BT474] 细胞, MCF7 [MCF-7] 细胞
-
Metadherin inhibits chemosensitivity of triple-negative breast cancer to paclitaxel via activation of AKT/GSK-3β signaling pathway(2023)
作者:Yan Chang, Hui-Qin Jia, Bin Xu, Liu Yang, Ye-Tong Xu, Jing-Yu Zhang, Mei-Qi Wang, Li-Xian Yang, Zhen-Chuan Song
期刊:Chemical Biology & Drug Design
影响因子:3.0
引用产品: MDA-MB-231 细胞, BT-549 细胞
-
Identification of TFR2 as a novel ferroptosis?related gene that serves an important role in prognosis and progression of triple?negative breast cancer(2023)
作者:Yan Yang, Jie Du, Yun-Fei Huang, Wei He, Li Liu, Dan Li, Rui Chen
期刊:Oncology Letters
影响因子:2.9
引用产品: MCF 10A 细胞, T-47D 细胞, SK-BR-3 [SKBR3] 细胞, BT-549 细胞, MDA-MB-468 细胞, MDA-MB-436 细胞, MDA-MB-231 细胞, 马血清, MEM非必需氨基酸溶液 (NEAA),100×
-
DNAJB4 suppresses breast cancer progression and promotes tumor immunity by regulating the Hippo signaling pathway(2023)
作者:Chen Yanru, Li Jingjia, Pu Lulan, Hu Jinghua, Fang Lingyu, Zhou Fangfang, Zhang Hongying, Yang Yi, Rong Xinxin, Deng Shishan, Hou Lingmi
期刊:Discover Oncology
DOI:10.1007/s12672-023-00762-8
影响因子:2.2
引用产品: BT-549 细胞, MCF 10A 细胞, MDA-MB-231 细胞, SK-BR-3 [SKBR3] 细胞, MCF7 [MCF-7] 细胞
-
FEZF2 inhibits the growth of triple-negative breast cancer cells through EZH2/PD-L1 and enhances anti-tumor immunity in vivo(2023)
作者:Li Wenyu, Liu Hu, Li Wenjuan, Zhang Qiujun, Zhang Qianyu, Hu Dandan
期刊:Molecular & Cellular Toxicology
DOI:10.1007/s13273-023-00368-9
影响因子:1.7
引用产品: MCF 10A 细胞, DMEM/F12 培养基, 马血清, 青霉素-链霉素溶液 (双抗),100×, MDA-MB-231 细胞, MDA-MB-468 细胞, DMEM高糖 培养基, BT-549 细胞, RPMI-1640 培养基, MDA-MB-436 细胞
-
Hsa-miR-497-3p impedes the proliferation and invasion of triple-negative breast cancer cells by controlling epithelial-mesenchymal transition through ZEB1 targeting(2023)
作者:Qian Dong, Hu Chen, Ying Li, Yan Kong, Cuizhi Geng, Yibing Liu
期刊:CELLULAR AND MOLECULAR BIOLOGY
影响因子:1.6
引用产品: MDA-MB-231 细胞, BT-549 细胞, MDA-MB-468 细胞, MCF7 [MCF-7] 细胞
-
Q1:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢?
部分细胞是会出现多种培养条件的,我们公司优先选择引种来源的培养条件以及建系者所用培养条件,出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件,为了避免细胞突然更换培养条件后不适应,建议您优先使用厂家推荐的培养条件培养。

识别码示意图